Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 335.6 M325.1 M377.6 M401.1 M 1.44 B Research & development ———— — Operating income 347.4 M-597.6 M280.1 M-1.66 B -1.63 B Non-Operating Income, Total 8.7 M9.9 M6.6 M28.2 M 53.4 M Interest expense, net of interest capitalized -2.1 M-1.8 M-1.8 M-2.1 M -7.8 M Non-Operating Income, excl. Interest Expenses 10.8 M11.7 M8.4 M30.3 M 61.2 M Unusual income/expense ———— — Pretax income 289.1 M-655.3 M229.6 M-1.69 B -1.82 B Equity in earnings 29.4 M32.2 M36.5 M42.6 M 140.7 M Taxes 124.6 M8.3 M29.8 M-70.9 M 91.8 M Non-controlling/minority interest 100 K000 — After tax other income/expense ———— — Net income before discontinued operations 164.5 M-663.6 M199.8 M-1.62 B -1.92 B Discontinued operations ———— — Net income 164.5 M-663.6 M199.8 M-1.62 B -1.92 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 164.5 M-663.6 M199.8 M-1.62 B -1.92 B Basic earnings per share (Basic EPS) 0.34-1.390.42-3.37 -4 Diluted earnings per share (Diluted EPS) 0.34-1.390.42-3.37 -4 Average basic shares outstanding 478.7 M479 M479 M479 M — Diluted shares outstanding 479.6 M479 M479.8 M479 M — EBITDA 238.4 M-714.5 M158.7 M-1.81 B -2.13 B EBIT 143.1 M-811.5 M57.3 M-1.92 B -2.53 B Cost of revenue 1.99 B2.28 B2.13 B2.18 B 8.58 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 95.3 M97 M101.4 M102.3 M 396 M